Zai Lab Limited (ZLAB) Earnings History
Annual and quarterly earnings data from 2015 to 2025
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 58.6% | -49.9% | -38.1% |
| 2024 | 62.9% | -70.7% | -64.4% |
| 2023 | 64.1% | -137.4% | -125.5% |
| 2022 | 65.6% | -188.0% | -206.1% |
| 2021 | 63.8% | -485.1% | -488.2% |
Download Data
Export ZLAB earnings history in CSV or JSON format
Free sign-in required to download data
Zai Lab Limited (ZLAB) Earnings Overview
As of February 28, 2026, Zai Lab Limited (ZLAB) reported trailing twelve-month net income of -$176M, reflecting +0.4% year-over-year growth. The company earned $-1.59 per diluted share over the past four quarters, with a net profit margin of -0.4%.
Looking at the long-term picture, ZLAB's historical earnings data spans multiple years. The company achieved its highest annual net income of -$18M in fiscal 2015.
Zai Lab Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to industry peers including UTHR ($1.33B net income, 0.4% margin), AMRN (-$86M net income, -0.4% margin), ALKS ($242M net income, 0.2% margin), ZLAB has room to improve margins relative to the peer group. Compare ZLAB vs UTHR →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
11 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$176M | +31.7% | -$229M | $-1.60 | -38.1% | -49.9% |
| 2024 | -$257M | +23.2% | -$282M | $-2.60 | -64.4% | -70.7% |
| 2023 | -$335M | +24.5% | -$367M | $-34.60 | -125.5% | -137.4% |
| 2022 | -$443M | +37.1% | -$404M | $-46.30 | -206.1% | -188.0% |
| 2021 | -$704M | -162.0% | -$700M | $-75.80 | -488.2% | -485.1% |
| 2020 | -$269M | -37.8% | -$302M | $-34.60 | -549.3% | -616.4% |
| 2019 | -$195M | -40.3% | -$203M | $-30.30 | -1502.3% | -1564.9% |
| 2018 | -$139M | -176.0% | -$142M | $-26.40 | -107433.6% | -109514.0% |
| 2017 | -$50M | -34.3% | -$51M | $-23.20 | - | - |
| 2016 | -$38M | -108.1% | -$39M | $-39.70 | - | - |
See ZLAB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZLAB Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ZLAB vs AGIO
See how ZLAB stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is ZLAB growing earnings?
ZLAB EPS of $-1.59 reflects slowing growth at +0.4%, below the 5-year CAGR of N/A. TTM net income is $-176M. Expansion rate has moderated.
What are ZLAB's profit margins?
Zai Lab Limited net margin is -0.4%, with operating margin at -0.5%. Below-average margins reflect competitive or cost pressures.
How consistent are ZLAB's earnings?
ZLAB earnings data spans 2015-2025. The current earnings trend is +0.4% YoY. Historical data enables comparison across business cycles.